EQTEC (EQT) Share Price, News & Analysis

Company Overview

EQTEC plc licenses and sells its proprietary advanced gasification technology that generates green energy from municipal, agricultural and industrial waste, biomass, and plastics in the Republic of Ireland, the United Kingdom, European Union, and the United States. The company operates in two segments, Technology Sales and Power Generation. It also provides engineering, design, and other related services, as well as maintenance services for operating plants; and engages in the development and operation of renewable energy electricity and heat generating plants. The company was formerly known as REACT Energy plc and changed its name to EQTEC plc in February 2017. EQTEC plc was founded in 1997 and is based in Cork, Ireland.

Key Stats

• Today's Range: 0.94 to 1
• 50-Day Range: 0.93 to 1.40
• 52-Week Range: 0.90 to 13
• Volume: 6.12 million shs
• Average Volume: 2.62 million shs
• Market Capitalization: £2.43 million
• P/E Ratio: N/A
• Dividend Yield: 1.83%
• Price Target: N/A
• Consensus Rating: N/A

EQT Stock Analysis - Frequently Asked Questions

How have EQT shares performed this year?

EQTEC's stock was trading at GBX 3 at the beginning of the year. Since then, EQT shares have decreased by 68.6% and is now trading at GBX 0.94.
View the best growth stocks for 2024 here.

How do I buy shares of EQTEC?

Shares of EQT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of EQTEC own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EQTEC investors own include Premier African Minerals (PREM), Keras Resources (KRS), Dynavax Technologies (DVAX), MOTIF BIO PLC/S (MTFB), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC) and BioCryst Pharmaceuticals (BCRX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Industrials
• Industry: Specialty Industrial Machinery
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: LON:EQT
• CUSIP: N/A
• CIK: N/A
• Web: www.eqtecplc.com
• Phone: +353-21-2409056
• Fax: N/A
• Employees: 740
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 2.91
• P/E Growth: N/A
• Net Income: £-23,780,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -81.51%
• Return on Assets: -15.58%

Debt

• Debt-to-Equity Ratio: 26.16
• Current Ratio: 1.80
• Quick Ratio: 0.84

Sales & Book Value

• Annual Sales: £2.55 million
• Price / Sales: 0.95
• Cash Flow: GBX 0.33 per share
• Price / Cash Flow: 2.85
• Book Value: GBX 13 per share
• Price / Book: 0.07

Miscellaneous

• Outstanding Shares: 257,610,000
• Free Float: N/A
• Market Cap: £2.43 million
• Optionable: Not Optionable
• Beta: 2.07